Back to search
Healthy Chinese Subjects
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Healthy Chinese Subjects trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Healthy Chinese Subjects trials you may qualify forA randomized, open-label, multiple-dose study to evaluate the effects of high-fat meals and different administration conditions (including water intake and fast…
The purpose of the study is to evaluate the safety of SPH9788 tablets in healthy subjects.
This study will consist of 2 parts: Part Ⅰ-in healthy adult subjects, Part Ⅱ-in adult patients with schizophrenia
This study adopts a randomized, double-blind, parallel placebo-controlled dose-escalation design, consisting of two parts: Part 1 includes a single ascending do…
The purpose of this study is to characterize the drug-drug intereaction of HDM1002 and metformin, empagliflozin, midazolam, valsartan, and warfarin in overweigh…
This is a Phase I clinical trial evaluating the safety, tolerability, and pharmacokinetic characteristics of single and multiple doses of CPD704 inhalation susp…
This is a randomized, double-blinded, controlled Phase I study of new process CMAB015 administered by subcutaneous injection. This study will characterize the p…
The objective of this study is to assess the pharmacokinetic (PK), immunogenicity, safety, and tolerability of ABBV-1451 after single ascending doses in healthy…